Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 5

The Effect of Serum Electrolyte Disturbances and Uric Acid Level on the Mortality of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Pages
322–328
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, the levels of these parameters should be measured and corrected during AECOPD treatment to decrease mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: The aim of the study was to determine the prevalence of electrolyte and uric acid disturbances and their effects on mortality in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
📊
Key Findings & Data:MATERIALS AND METHODS: This study included all consecutive AECOPD patients who were managed at our Chest Diseases department between May 2017 and December 2017.
💡
Conclusion & Impact:In conclusion, the levels of these parameters should be measured and corrected during AECOPD treatment to decrease mortality.
🔬Design:Review & Systematic Survey
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: The aim of the study was to determine the prevalence of electrolyte and uric acid disturbances and their effects on mortality in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). MATERIALS AND METHODS: This study included all consecutive AECOPD patients who were managed at our Chest Diseases department between May 2017 and December 2017. Medical records of all the subjects were reviewed, and data were collected retrospectively. Eighty-one patients with AECOPD and 103 subjects in the control group were enrolled retrospectively. The association between the COPD and control groups and biochemical parameters in patients with and without long-term oxygen therapy and noninvasive mechanical ventilation treatment in COPD patients were compared with mortality.RESULTS: Serum magnesium , phosphorus , potassium , sodium, and calcium (Ca levels were higher in control subjects than in COPD patients (p=0.006, p=0.015, and p<0.001, respectively). While serum levels of Ca and K were significantly lower and serum level of uric acid was higher in deceased COPD patients than in alive AECOPD patients (p=0.023, p=0.001, and p=0.033, respectively), serum levels of Mg, P, and other biochemical parameters were similar.CONCLUSION: Serum Ca, K, and uric acid levels during the exacerbation period were significant predictors of mortality in COPD patients. In conclusion, the levels of these parameters should be measured and corrected during AECOPD treatment to decrease mortality.

🔖

Cite This Article

OGAN, N., GÜNAY, E., BAHA, A., ÇANDAR, T., AKPİNAR, E. E. (2020). The Effect of Serum Electrolyte Disturbances and Uric Acid Level on the Mortality of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Turkish Thoracic Journal, Cilt: 21 - Sayı: 5, 322–328. https://ajindex.com/articles/417940

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. GOLD Global Initiative for Chronic Obstructive Lung Disease. 2018. pp. 1-123
  2. Goli G, Mukka R, Sairi S. Study of serum electrolytes in acute exacerbation of chronic obstructive pulmonary disease patients. Int J Res Med Sci 2016;4:3324-7. [Crossref] 3. Das P, Bandyopadhyay M, Baral K, et al. Dyselectrolytemia in Chronic Obstructive Pulmonary Diseases with acute exacerbation. Nig J Physiol Sci 2010;25:25-7
  3. Zhao Y, Li Z, Shi Y, et al. Effect of hypophosphatemia on the withdrawal of mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease. Biomed Rep 2016;4:413-6. [Crossref] 5. Terzano C, Conti V, Di Stefano F, et al. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 2010;188:321-9. [Crossref] 6. Terzano C, Stefano FD, Conti V, et al. Mixed Acid-Base Disorders, Hydroelectrolyte Imbalance and Lactate Production in Hypercapnic Respiratory Failure: The Role of Noninvasive Ventilation. PLoS One 2012;7:e35245. [Crossref] 7. Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 2013;9:13-23. [Crossref] 8. Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol 2014;26:186-91. [Crossref] 9. Zhang X, Liu L, Liang R, R, et al. Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:2519- 23. [Crossref] 10. Pinheiro Besen BAM, Nunes Gobatto AL, Garcia Melro LM. Fluid and electrolyte overload in critically ill patients: An overview. World J Crit Care Med 2015;4;4:116-29. [Crossref] 11. Ouf FM, Abdel Aziz AF, Wahba AH, et al. Electrolyte disturbances and their impact on mechanically ventilated patients with acute exacerbation of chronic obstructive pulmonary disease. AAMJ 2015;13:27-33
  4. Billington CK, Penn RB, Hall IP. β2-agonists. Handb Exp Pharmacol 2017;237:23-40. [Crossref] 13. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013;9:1-25. [Crossref] 14. Huertas A, Palange P. COPD: a multifactorial systemic disease. Ther Adv Respir Dis 2011;5:217-24. [Crossref] 15. Dimai HP, Domej W, Leb G, et al. Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res 2001;16:2132-41. [Cr